Activesite Pharmaceuticals, Inc.

Berkeley, CA 94710

SBIR Award Summary

Total Number of Awards 5
Total Value of Awards $2.41MM
First Award Date 09/10/07
Most Recent Award Date 03/01/13

Key Personnel

Last Name Name Awards Contact
Chilcote Tamie Chilcote 5

5 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-050
Budget: 03/01/13 - 02/28/14

DESCRIPTION (provided by applicant): There are nearly 24 million people in the U.S. who suffer from diabetes and all are at risk for developing diabetic macular edema (DME), a vision-threatening retinal complication of diabetes that is the leading cause of blindness in working age adults. Current prevalence of DME in the U.S. is estimated to ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-050
Budget: 03/01/12 - 02/28/13

DESCRIPTION (provided by applicant): There are nearly 24 million people in the U.S. who suffer from diabetes and all are at risk for developing diabetic macular edema (DME), a vision-threatening retinal complication of diabetes that is the leading cause of blindness in working age adults. Current prevalence of DME in the U.S. is estimated to ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-050
Budget: 07/01/10 - 07/30/11

DESCRIPTION (provided by applicant): There nearly 24 million people in the U.S. who suffer from diabetes and who are at risk for diabetic retinopathy (DR), a vascular complication of diabetes that is the leading cause of blindness in working age adults. A major cause of vision loss in DR is increased retinal vascular permeability (RVP), leading ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-050
Budget: 07/01/09 - 06/30/10

DESCRIPTION (provided by applicant): There nearly 24 million people in the U.S. who suffer from diabetes and who are at risk for diabetic retinopathy (DR), a vascular complication of diabetes that is the leading cause of blindness in working age adults. A major cause of vision loss in DR is increased retinal vascular permeability (RVP), leading ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-20
Budget: 09/10/07 - 08/31/08

DESCRIPTION (provided by applicant): More than 850,000 myocardial infarctions (MI) occur in the US annually, 300,000 of which are recurrences, carrying with them a two-fold increased risk of death. Recurrent MI take place owing to the high rates of reocclusion of cardiac arteries observed following initially successful fibrinolytic therapy with ...